426 related articles for article (PubMed ID: 17107885)
1. An in vitro model of early islet amyloid polypeptide (IAPP) fibrillogenesis using human IAPP-transgenic mouse islets.
Henson MS; Buman BL; Jordan K; Rahrmann EP; Hardy RM; Johnson KH; O'Brien TD
Amyloid; 2006 Dec; 13(4):250-9. PubMed ID: 17107885
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.
Jaikaran ET; Nilsson MR; Clark A
Biochem J; 2004 Feb; 377(Pt 3):709-16. PubMed ID: 14565847
[TBL] [Abstract][Full Text] [Related]
3. Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide.
de Koning EJ; Morris ER; Hofhuis FM; Posthuma G; Höppener JW; Morris JF; Capel PJ; Clark A; Verbeek JS
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8467-71. PubMed ID: 8078905
[TBL] [Abstract][Full Text] [Related]
4. The effect of apolipoprotein E deficiency on islet amyloid deposition in human islet amyloid polypeptide transgenic mice.
Vidal J; Verchere CB; Andrikopoulos S; Wang F; Hull RL; Cnop M; Olin KL; LeBoeuf RC; O'Brien KD; Chait A; Kahn SE
Diabetologia; 2003 Jan; 46(1):71-9. PubMed ID: 12637985
[TBL] [Abstract][Full Text] [Related]
5. Islet amyloid polypeptide: mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus.
Johnson KH; O'Brien TD; Betsholtz C; Westermark P
Lab Invest; 1992 May; 66(5):522-35. PubMed ID: 1573849
[TBL] [Abstract][Full Text] [Related]
6. Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model.
Höppener JW; Oosterwijk C; Nieuwenhuis MG; Posthuma G; Thijssen JH; Vroom TM; Ahrén B; Lips CJ
Diabetologia; 1999 Apr; 42(4):427-34. PubMed ID: 10230646
[TBL] [Abstract][Full Text] [Related]
7. Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced beta-cell apoptosis in h-IAPP transgenic mice.
Lin CY; Gurlo T; Kayed R; Butler AE; Haataja L; Glabe CG; Butler PC
Diabetes; 2007 May; 56(5):1324-32. PubMed ID: 17353506
[TBL] [Abstract][Full Text] [Related]
8. Identification of the amyloid-degrading enzyme neprilysin in mouse islets and potential role in islet amyloidogenesis.
Zraika S; Hull RL; Udayasankar J; Clark A; Utzschneider KM; Tong J; Gerchman F; Kahn SE
Diabetes; 2007 Feb; 56(2):304-10. PubMed ID: 17259373
[TBL] [Abstract][Full Text] [Related]
9. Islet pathology of non-insulin-dependent diabetes mellitus (NIDDM).
Westermark P
Diabet Med; 1996 Sep; 13(9 Suppl 6):S46-8. PubMed ID: 8894481
[TBL] [Abstract][Full Text] [Related]
10. DPP-4 inhibition improves glucose tolerance and increases insulin and GLP-1 responses to gastric glucose in association with normalized islet topography in mice with beta-cell-specific overexpression of human islet amyloid polypeptide.
Ahrén B; Winzell MS; Wierup N; Sundler F; Burkey B; Hughes TE
Regul Pept; 2007 Oct; 143(1-3):97-103. PubMed ID: 17482289
[TBL] [Abstract][Full Text] [Related]
11. [Construction of transgenic mouse system expressing human islet amyloid polypeptide (IAPP)/amylin].
Yagui K; Kanatsuka A; Makino H
Nihon Rinsho; 1994 Oct; 52(10):2746-50. PubMed ID: 7983808
[TBL] [Abstract][Full Text] [Related]
12. Islet amyloid polypeptide in proliferating pancreatic B cells during development, hyperplasia, and neoplasia in humans and mice.
Rindi G; Terenghi G; Westermark G; Westermark P; Moscoso G; Polak JM
Am J Pathol; 1991 Jun; 138(6):1321-34. PubMed ID: 1647136
[TBL] [Abstract][Full Text] [Related]
13. Islet amyloid polypeptide inserts into phospholipid monolayers as monomer.
Engel MF; Yigittop H; Elgersma RC; Rijkers DT; Liskamp RM; de Kruijff B; Höppener JW; Antoinette Killian J
J Mol Biol; 2006 Feb; 356(3):783-9. PubMed ID: 16403520
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
[TBL] [Abstract][Full Text] [Related]
15. Effects of free fatty acid on polymerization of islet amyloid polypeptide (IAPP) in vitro and on amyloid fibril formation in cultivated isolated islets of transgenic mice overexpressing human IAPP.
Ma Z; Westermark GT
Mol Med; 2002 Dec; 8(12):863-8. PubMed ID: 12606822
[TBL] [Abstract][Full Text] [Related]
16. ABCA1 deficiency and cellular cholesterol accumulation increases islet amyloidogenesis in mice.
Wijesekara N; Kaur A; Westwell-Roper C; Nackiewicz D; Soukhatcheva G; Hayden MR; Verchere CB
Diabetologia; 2016 Jun; 59(6):1242-6. PubMed ID: 26970755
[TBL] [Abstract][Full Text] [Related]
17. Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus.
Johnson KH; O'Brien TD; Betsholtz C; Westermark P
N Engl J Med; 1989 Aug; 321(8):513-8. PubMed ID: 2668761
[TBL] [Abstract][Full Text] [Related]
18. Amyloid fibril formation is progressive and correlates with beta-cell secretion in transgenic mouse isolated islets.
MacArthur DL; de Koning EJ; Verbeek JS; Morris JF; Clark A
Diabetologia; 1999 Oct; 42(10):1219-27. PubMed ID: 10525663
[TBL] [Abstract][Full Text] [Related]
19. Human islet amyloid polypeptide accumulates at similar sites in islets of transgenic mice and humans.
de Koning EJ; Höppener JW; Verbeek JS; Oosterwijk C; van Hulst KL; Baker CA; Lips CJ; Morris JF; Clark A
Diabetes; 1994 May; 43(5):640-4. PubMed ID: 8168639
[TBL] [Abstract][Full Text] [Related]
20. Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes.
Matveyenko AV; Butler PC
Diabetes; 2006 Jul; 55(7):2106-14. PubMed ID: 16804082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
